Looking Beyond 2022 – Future Directions for CRISPR
Time: 8:45 am
day: Day Two
Details:
- Outlining the latest advances and developments in CRISPR-based therapies, with a focus on in vivo applications
- Exploring future directions for current gene editing companies including base, prime and epigenome editing technologies
- Understand what current obstacles and challenges are holding in vivo gene editing therapeutics back from success
